An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Science

Topics

Biology

Biochemistry

Chemistry

Medicine

Internal Medicine

Show all topics

DOI

10.1126/science.abl4784

License

CC-BY

Other Formats

PDF